biomarker analysis of cobrim: phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
Published 9 years ago • 100 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
3:33
cobimetinib plus vemurafenib for advanced braf-mutated melanoma
-
2:36
hamid: cobimetinib, zelboraf for previously untreated melanoma
-
2:02
trial results of vemurafenib, cobimetinib and ldh as a predictive marker in braf-mutated melanoma
-
24:19
advanced melanoma: the evolving role of biomarker testing in treatment and prognosis
-
0:51
dr. mcarthur discusses subpopulation data from cobrim trial in advanced melanoma
-
6:36
imspire 150: atezolizumab, cobimetinib and vemurafenib in untreated patients with brafv600 mutat...
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
7:58
regulatory approvals for vemurafenib/cobimetinib, necitumumab, and elotuzumab
-
1:03
dr. chapman describes the vemurafenib clinical trial
-
2:08
assessing textbook outcomes in borderline resectable stage iiib-d and iv melanoma
-
25:41
new immunotherapies, precision medicine and biomarkers in melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
7:48
the current understanding of biomarkers in melanoma
-
0:58
dr. antoni ribas on combining vemurafenib and ipilimumab for metastatic melanoma
-
1:42
dr. weber on biomarker data from checkmate-238 for melanoma
-
2:21
dr. omid hamid on vemurafenib and atezolizumab in melanoma
-
3:52
understanding your biomarker test report
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer